SOM Biotech announces that it has obtained an INNOVATIVE SME seal from the Ministry of Science and Innovation.

This distinction recognizes SOM Biotech’s contribution to R&D innovation. The accreditation highlights the innovative business model, based on a pioneering computational chemistry technology that the company has developed to accelerate and streamline the drug discovery and development process.

Maria Zimina, Business Development Manager, underlines: “Innovation is at the core of SOM Biotech´s business model. We work with a proprietary technology based on artificial intelligence to identify drug candidates with high levels of safety and efficacy. This has allowed us to build a very robust portfolio of drug candidates for diseases where there is a great medical need. Our technology is validated through the positive results we have obtained in different clinical trials. We have also proved that drug development times can be shortened and R&D costs can be drastically lowered, benefiting patients with severe medical conditions.”

Read the post in Spanish here.

innovative company

Leave a Reply

Your email address will not be published. Required fields are marked *



    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.